| Pharmascience | pms-Sitagliptin | New Product | Nouveau produit | We are pleased to announce the launch of pms-SITAGLIPTIN! |  | 02503840 |
| Sandoz | Rivastigmine capsules | Discontinuation | Abandon de produit | Sandoz Canada wishes to inform you that Sandoz Rivastigmine capsules will be no longer available upon depletion of inventory.
|  | 00000 |
| Pharmascience | Duloxetine 30mg 1000 CAPS | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following products:
pms-DULOXETINE 30mg CAPS 1000, you may place your order now. |  | 2429446 |
| Pharmascience | Palbociclib | New Product | Nouveau produit | New product launch of pms-Palbociclib. |  | 02552132 |
| Pharmascience | pms-DULOXETINE 60mg CAPS 500 | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-DULOXETINE 60mg CAPS 500, you may place your order now. |  | 2429454 |
| Sandoz | Alendronate, Dimethyl Fumarate, Finasteride | Discontinuation | Abandon de produit | Sandoz Canada wishes to inform you that the following products will be no longer available upon depletion of inventory. |  | 0000000 |
| Pharmascience | pms-DAPAGLIFLOZIN | Product Appearance Up date | Nouvel aspect du produit | We would like to inform you of the change in appearance of pms-DAPAGLIFOZIN 5MG & 10MG. Please take a few minutes to review the information below. |  | 02531550 |
| Sandoz | Sandoz Bilastine | New Product | Nouveau produit | We are glad to share the launch of PrSandoz® Bilastine |  | 02536269 |
| Sandoz | Pr SANDOZ® FESOTERODINE FUMARATE | Product Availability | Disponibilité des produits | Sandoz Canada wishes to inform you that the following product Pr SANDOZ® FESOTERODINE FUMARATE 8 MG 100 TABLETS will be unavailable for an indefinite period of time.
Rest assured; we are doing our utmost to ensure the continuity of supply of the replacement product Pr Sandoz® Fesoterodine fumarate 8mg in bottles of 30 tablets. |  | 02521776 |
| Pharmascience | PERIOSTAT | Product Transition | Transition dans la production | We are pleased to announce the commercial transfer of PERIOSTAT 20mg Capsules from Pendopharm to Pharmascience Canada effective October 15th, 2024. |  | 02247104 |
| Sandoz | Sandoz AFAtinib | New Product | Nouveau produit | We are glad to share the launch of PrSandoz® AFAtinib. |  | 02512777 |
| Pharmascience | pms-GABAPENTIN 100mg CAPS 1000 | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product:
pms-GABAPENTIN 100mg CAPS 1000, you may place your order now.
|  | 02243446 |
| Pharmascience | PMS-AMLODIPINE | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following products:
pms-AMLODIPINE 5mg TABS 2000 / 10mg TABS 1000, you may place your order now. |  | 2284065 |
| Pharmascience | | None Selected | | | |
| Pharmascience | PMS-CLONAZEPAM-R | Product Transition | Transition dans la production | Dear Customer, Pharmascience is pleased to announce the product change of PMS-CLONAZEPAM to PMS-CLONAZEPAM-R. |  | 02048701 |
| Pharmascience | pms-Escitalopram 10mg | Product Availability | Disponibilité des produits | We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-Escitalopram 10mg blisters. Consequently we will be out of stock for an extended period of time |  | 02469243 |
| Pharmascience | pms-ROSUVASTATIN 20mg TABS 1500 | New pack size | Nouveau format | Dear Customer, Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-ROSUVASTATIN 20mg TABS 1500. |  | 02378558 |
| Sandoz | Multiple Products | Discontinuation | Abandon de produit | Discontinuation Notice
Multiple products | | |
| Pharmascience | | New pack size | Nouveau format | Dear Customer,
Pharmascience Canada is please to announced the relaunch of the following products:
pms-DEFERASIROX (TYPE J) 90mg, 180mg and 360mg TABS 30 BTL, are now available and you may place your order now. |  | 2528290 |
| Sandoz | PrSandoz® Dutasteride | New Product | Nouveau produit | We’re glad to share the return of PrSandoz® Dutasteride 0.5 mg available in blister packs of 30 and bottles of 100 capsules.
|  | 02424444 |
| Sandoz | Sandoz® Desvenlafaxine | New Product | Nouveau produit | We’re glad to share the launch of Sandoz® Desvenlafaxine. |  | 02538415 |
| Sandoz | Sandoz Rivastigmine Patch | Information Update | Mise à jour des renseignements | Sandoz Canada wishes to inform you that a downloadable tool is available for your patients who take Sandoz® Rivastigmine Patch. The tool is a multiple-page digital patient diary (one page per week) that can be printed out. It contains instructions for administering PrSandoz® Rivastigmine Patch and a place to record their use. |  | 02426293 |
| Sandoz | Sandoz® Bisoprolol | New Product | Nouveau produit | Sandoz® Bisoprolol new strengths.
We're glad to share the launch of Sandoz® Bisoprolol 1.25 mg and 2.5 mg.
• NEW CONCENTRATIONS exclusive to Sandoz 1.25 mg and 2.5 mg.
• Scored tablets in 2.5 mg, 5 mg and 10 mg strengths.
• Concentrations clearly indicated on tablets.
• All strengths available in bottles of 100 tablets.
|  | 02544245 |
| Sandoz | Sandoz Lisdexamfetamine | New Product | Nouveau produit | We are glad to share the launch of Sandoz® Lisdexamfetamine. |  | 02546248 |
| Pharmascience | pms-TRAZODONE | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product: pms-TRAZODONE 50mg TABS 1500, you may place your order now. |  | 01937227 |
| Sandoz | Sandoz® Gliclazide MR and Sandoz® Pravastatin | Discontinuation | Abandon de produit | Discontinuation Notice
Sandoz Canada wishes to inform you that we are discontinuing Sandoz® Gliclazide MR and Sandoz® Pravastatin. The products will be no longer available upon depletion of inventory (date communicated below is subjected to change).
Please accept our apologies for any inconvenience this may cause.
|  | 02461323 |
| Sandoz | Sandoz Docusate Sodium | Discontinuation | Abandon de produit | Discontinuation Notice
Sandoz® Docusate Sodium |  | |
| Pharmascience | pms-PERINDOPRIL 8mg | New pack size | Nouveau format | Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-PERINDOPRIL 8mg TABS 1000. |  | 02470691 |
| Pharmascience | pms-FLUOXETINE 20mg CAPS | New pack size | Nouveau format | Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-FLUOXETINE 20MG CAPS 1000 and is now available to order. |  | 02177587 |
| Pharmascience | PERICHLOR 0.12% ORAL RINSE | Important Announcement | Annonce importante | Effective June 1st, 2024, the following products will be transferred from Pendopharm, division of Pharmascience Inc. to Pharmascience Inc. |  | 02493160 |
| Pharmascience | | None Selected | | | |
| Sandoz | | None Selected | | | |
| Pharmascience | pms-ROSUVASTATIN 5mg TABS 3000 | New pack size | Nouveau format | Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-ROSUVASTATIN 5mg TABS 3000. | | 02378523 |
| Sandoz | Sandoz Gliclazide MR | Product Availability | Disponibilité des produits | See PDF |  | 02314177 |
| Sandoz | NYPOZI | New Product | Nouveau produit | NYPOZI (filgrastim) is now available! |  | 02520990 |
| Sandoz | NYPOZI - ZIEXTENZO | New Product | Nouveau produit | Now offering the complete G-CSF portfolio |  | 02520990 |
| Pharmascience | | None Selected | | | |
| Pharmascience | pms-DICLOFENAC 1.5% SOL TOPI 60 mL | Product Availability | Disponibilité des produits | We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-DICLOFENAC 1.5% SOL TOPI 60 mL. Consequently we will be out of stock for an extended period of time. |  | 02356783 |
| Pharmascience | pms-METHOTREXATE 50MG/ML | New Product | Nouveau produit | Pharmascience Canada is pleased to announce the launch of pms-METHOTREXATE 50MG/ML, you may place your order now. |  | 2539608 |
| Pharmascience | pms-PERINDOPRIL-AMLODIPINE | New Product | Nouveau produit | Pharmascience Canada is pleased to announce the launch of pms-PERINDOPRIL-AMLODIPINE, you may place your order now. |  | 02541696 |
| Pharmascience | pms-CITALOPRAM HBR 40mg TAB 1100, | New pack size | Nouveau format | Pharmascience Canada is please to announced the launch of a new large format for the following product:
pms-CITALOPRAM HBR 40mg TAB 1100, you may place your order now. |  | 02248011 |
| Sandoz | Sandoz Apremilast | New pack size | Nouveau format | Sandoz Apremilast Started Kit now available |  | 02529092 |
| Sandoz | Sandoz Omeprazole | Discontinuation | Abandon de produit | Discontinuation Notice Sandoz® Omeprazole 10 mg |  | 02296438 |
| Pharmascience | pms-PREGABALIN 150mg 800 | New pack size | Nouveau format | Dear Customer,
Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-PREGABALIN 150mg CAPS 800 and you may place your order now. | | 2359634 |
| Pharmascience | pms-LACTULOSE-PHARMA 667mg/mL | Product Transition | Transition dans la production | Dear Customer,
Pharmascience is pleased to announce the product change of pharma-LACTULOSE 667mg/mL 500mL to pms-LACTULOSE-PHARMA 667mg/mL 500mL and 1000mL, effective immediately. |  | 02247383 |
| Pharmascience | pms-QUINAPRIL 40mg TABS 100 | Product Availability | Disponibilité des produits | Dear client,
Pharmascience Canada is pleased to announce that pms-QUINAPRIL 40mg TABS 100 is now back in stock and you may place
your order now. |  | 02340585 |
| Pharmascience | SILDENAFIL 100mg | Product Transition | Transition dans la production | Pharmascience is pleased to announce the product change of SILDENAFIL 100mg TABS 30 to SILDENAFIL 100mg TABS BLI 1X 4, effective immediately. |  | 02317583 |
| Pharmascience | pms-TERAZOSIN 2mg TABS 100 | Product Appearance Up date | Nouvel aspect du produit | Dear Customer,
We would like to inform you of the change in appearance of pms-TERAZOSIN 2mg tablets. This change is effective immediately. Please take a few minutes to review the information below. |  | 02243519 |
| Pharmascience | pms-LITHIUM CARBONATE 300mg CAPS 100 | Product Availability | Disponibilité des produits | Dear Customer,
We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-LITHIUM CARBONATE 300mg CAPS 100. Consequently we will be out of stock for an extended period of time. |  | 02216140 |
| Pharmascience | pms-PAZOPANIB | New Product | Nouveau produit | Now available pms-PAZOPANIB 200 mg
Antineoplastic Agent
A generic equivalent to VOTRIENT |  | 02525666 |
| Pharmascience | pms-MONTELUKAST CHEW | New pack size | Nouveau format | Dear Customer,
Pharmascience is pleased to announce the product change of pms-MONTELUKAST CHEW 4mg TABS BLI 3X10 to pms-MONTELUKAST CHEW 4mg TABS 100. |  | 02354977 |
| Sandoz | Amlodipine 2.5 mg | New pack size | Nouveau format | We would like to inform you that Pr Sandoz ® Amlodipine 2.5 mg is now available in a bottle format of 500
tablets and available through wholesalers. |  | 02330474 |
| Pharmascience | PHARMASCIENCE NEW XL FORMATS | New pack size | Nouveau format | Dear Customer,
Pharmascience Canada is please to announced the launch of a new large format for the following products: pms-SERTRALINE HCL 100mg CAPS 800, pms-PREGABALIN 25mg CAPS 1400, pms-PREGABALIN 50mg CAPS 1000 and pms-ZOPICLONE 7.5mg and you may place your order now.
Regards,
Pharmascience Canada |  | 02244840, 02359596, 02359618, 02240606 |
| Pharmascience | PHARMASCIENCE NEW XL FORMATS | New pack size | Nouveau format | Dear Customer,
Pharmascience Canada is please to announced the launch of a new large format for the following products: pms-CITALOPRAM HBR 20mg TAB 2900, pms-PERINDOPRIL 4mg TAB 1500 and pms-PREGABALIN 75mg CAP 1400, you may place your order now.
Best regards,
Pharmascience Canada |  | 02248010, 02470683, 02359626 |
| Pharmascience | pms-DIGOXIN 0.05mg/mL ORAL SOL 115mL | Product Transition | Transition dans la production | Dear Customer,
Pharmascience is pleased to announce the product change of TOLOXIN 0.05mg/mL ORAL SOL 115mL to pms-DIGOXIN 0.05mg/mL ORAL SOL 115mL, effective immediately.
Best regards,
Pharmascience Canada
|  | 02242320 |
| Pharmascience | | None Selected | | | 02533332 |
| Pharmascience | pms-CIPROFLOXACIN XL | Product Availability | Disponibilité des produits | Dear Customer,
We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-CIPROFLOXACIN XL 500mg TABS 100. Consequently we will be out of stock for an extended period of time. |  | 2416433 |
| Pharmascience | OLESTYR REGULAR & LIGHT POWDER (ORANGE) | Important Announcement | Annonce importante | Dear,
This is to inform you that since August 16, our Olestyr Regular and sugar-free product (DINs 02210320 & 00890960) is no longer covered by the Régie d'Assurance Médicaments du Québec (RAMQ).
We were obliged to remove these products from the List of Medicines for economic reasons. The non-viability of this product at the current reimbursement price established by the RAMQ has forced to adjust our price.
For more information, please find attached the official communication for your ready reference.
Please do not hesitate to contact us if you have any questions regarding this communication.
Sincerely,
Pharmascience Canada | | 02210320, 00890960 |
| Pharmascience | Perindopril-Indapamide | New Product | Nouveau produit | Pharmascience is pleased to announce the launch of pms- PERINDOPRIL-INDAPAMIDE! |  | 02537990,02538008,02537982 |
| Sandoz | Sandoz Diclofenac SR | Discontinuation | Abandon de produit | Dear Customer,
Sandoz Canada Inc wishes to inform you that Sandoz Diclofenac SR 100 mg will be no longer available
upon depletion of inventory. Please accept our apologies for any inconvenience this may cause.
For more information, please contact your local Sandoz regional sales manager or call our customer service at 1 800 361 3062.
Thank you for your understanding. |  | 02261944 |
| Pharmascience | pmsc-METFORMIN 500mg and 850mg | Product Appearance Up date | Nouvel aspect du produit | Dear Customer,
We would like to inform you of the change in appearance of pmsc-METFORMIN 500mg and 850mg tablets. These changes will be in effect by early September 2023. Please take a few minutes to review the information below.
Regards,
Pharmascience Canada |  | 02520303, 02520311 |
| Sandoz | Sandoz® Losartan and Sandoz® Losartan HCT | New pack size | Nouveau format | We would like to inform you that Sandoz® Losartan and Sandoz® Losartan HCT are now available in 30 tablet blister packs and are available through wholesalers.
|  | 02313340, 02313359, 02313375, 02362449, 02313383 |
| Pharmascience | pms-RAMIPRIL-HCTZ 10/25mg TABS | Product Transition | Transition dans la production | Dear Customer,
Pharmascience is pleased to announce the product change of pms-RAMIPRIL-HCTZ 10/25mg TABS BL 2X15 to pms-RAMIPRIL-HCTZ 10/25mg TABS 100.
Regards,
Pharmascience Canada |  | 02342170 |
| Pharmascience | TOLOXIN 0.0625mg & 0.125ng TABS 250 to pms-DIGOXIN 0.0625mg & 0.125mg TABS 250 | Product Transition | Transition dans la production | Dear Customer,
PHARMASCIENCE is pleased to announce the product change of TOLOXIN 0.0625mg & 0.125mg tabs 250 to pms-DIGOXIN 0.0625mg & 0.125mg tabs 250, effective immediately.
Regards,
Pharmascience Canada |  | 02335700 & 02335719 |
| Sandoz | Pr Daptomycin for injection | New pack size | Nouveau format | Packaging change for Pr Daptomycin for injection |  | 02490838 |
| Sandoz | Pr Gemcitabine injection | New pack size | Nouveau format | New packaging |  | 02412292 |
| Pharmascience | pms-FLUTICASONE HFA 50mcg/ACT 120 | New Product | Nouveau produit | Hello All,
We are pleased to announce the launch of pms- FLUTICASONE HFA 50mcg/ACT in Ontario and Quebec only.
Regards,
Pharmascience Canada
|  | 02503115, 02503123, 02503131 |
| Pharmascience | pms-QUINAPRIL 5mg, 10mg and 20mg TABS 100 | Product Availability | Disponibilité des produits | Dear Customer,
Pharmascience Canada is pleased to announce that pms-QUINAPRIL 5mg, 10mg and 20mg TABS 100 are now back in stock and you may place your order now.
Best regards,
Pharmascience Canada |  | 02340550, 02340569, 02340577 |
| Sandoz | Sandoz Sunitinib | New Product | Nouveau produit | New product |  | NA |
| Sandoz | Sandoz Dapagliflozin | New Product | Nouveau produit | Launch of Sandoz Dapagliflozin |  | NA |
| Pharmascience | pms-Dapagliflozin | New Product | Nouveau produit | Pharmascience is pleased to announce the launch of pms- DAPAGLIFLOZIN! |  | 0231550,0231569 |
| Sandoz | PrClindamycin Injection USP-60ml | Product Availability | Disponibilité des produits | Now available |  | 02230535 |
| Pharmascience | pms-CLARITHROMYCIN 250mg & 500mg Tabs | Discontinuation | Abandon de produit | Dear Customer,
After careful consideration of our product portfolio, the decision has been made to cease production of the pms-CLARITHROMYCIN 250mg & 500mg tabs 100 for the Canadian market effective immediately. These skus will be removed from our product catalogue. Please note that Pharmascience remains the owner of the product DIN's.
Please accept our sincere apologies for any inconvenience that this may cause.
Best regards,
Pharmascience Canada |  | 02247573, 02247574 |
| Sandoz | Sandoz Alfacalcidol | New Product | Nouveau produit | Sandoz is proud to announce the launch of Sandoz Alfacalcidol. |  | 02533316,02533324 |
| Pharmascience | pms-PIRFENIDONE | New Product | Nouveau produit | We are pleased to announce the launch of pms- PIRFENIDONE! |  | 02531526, 02531534 |
| Pharmascience | METHOTREXATE Injection PFS 25mg/mL | New Product | Nouveau produit | Pharmascience is pleased to announce the launch of METHOTREXATE Injection PFS 25mg/mL. For more information on our product, please see the attachment.
Please don’t hesitate to contact us should you have any questions. |  | 02422204 |
| Sandoz | Sandoz Indomethacin & Sandoz Prochlorperazine | Important Announcement | Annonce importante | Dear Customer,
Sandoz wishes to inform you that on March 1, 2023, Sandoz and Odan entered into an asset purchase agreement whereby Sandoz is divesting PrSandoz® Indomethacin and PrSandoz® Prochlorperazine to Odan. This agreement includes DINs but excludes Sandoz current available inventories. Odan is a Canadian specialty pharmaceutical company, headquartered in Montreal, with fully integrated infrastructures for R&D, manufacturing and distribution and a market leader for suppositories.
Due to production constraints at the current manufacturing plant, following the acquisition, Odan will begin the site transfer process to its facility in Montreal. This will cause a temporary supply disruption of the products for several months (see table below for more information.) Rest assured that Sandoz and Odan are working closely together to bring the products back on the market as soon as possible.
Effective as of October 31, 2023, Odan will handle ordering, billing, shipping and returns relating to the Products. Prior to that date, Sandoz will remain responsible for all functions, including returns of the Products. |  | 02231799,02231800,00789720 |
| Sandoz | Sandoz Montelukast | Product Appearance Up date | Nouvel aspect du produit | Dear Customer,
Sandoz Canada Inc. would like to inform you that there will be an appearance change for PrSandoz® Montelukast 10 mg tablets upon depletion of current inventory. Please note that the UPC code will also change. |  | 02328593 |
| Pharmascience | pmsc-ESOMEPRAZOLE DR | New Product | Nouveau produit | Pharmascience is proud to offer pmsc-ESOMEPRAZOLE DR now available in both strengths 20mg and 40mg! |  | 02528479,02528487 |
| Pharmascience | OCTASA 1600 mg, mesalamine delayed-release oral tablets | New Product | Nouveau produit | Pendopharm, division of Pharmascience Inc., is pleased to announce the launch of OCTASA® 1600 mg effective immediately.
OCTASA® 1600 mg (mesalamine [also known as 5-aminosalicylic acid (5-ASA)] delayed-release oral tablets) is indicated for the induction of remission of moderate active ulcerative colitis (UC).
It’s the highest-strength mesalamine available in Canada, offering to your patients dosing simplicity and improving treatment adherence .
Want to find out more about OCTASA® 1600 mg? Feel free to reach out to Pendopharm Medical Information: 1-888-550-6060 or medinfo@pendopharm.com
|  | 02529610 |
| Pharmascience | pms-ATOMOXETINE 10mg TABS | Product Transition | Transition dans la production | Dear Customer,
Pharmascience is pleased to announce the product change of pms-ATOMOXETINE 10mg TABS BLI 2x15 to pms-ATOMOXETINE 10mg TABS BLI 3x10, effective immediately.
To place an order for pms-ATOMOXETINE 10mg TABS BLI 3x10, please contact your preferred distributor.
For any inquiries related to pms-ATOMOXETINE 10mg TABS BLI 3x10, please contact Pharmascience Customer Service at 1-800-340-
9735 or via email at customercarepms@pharmascience.com
Best regards,
Isabelle Bragoli
Product Manager
Pharmascience Canada |  | 02381028 |
| Pharmascience | pms-MONTELUKAST CHEW 4mg TABS 100 | Product Transition | Transition dans la production | Please see attached. |  | 02354977 |
| Pharmascience | pms-MONTELUKAST CHEW 5mg TABS BLI 3X10 | Product Availability | Disponibilité des produits | Please see attached. |  | 02354985 |
| Mylan | Dymista | Information Update | Mise à jour des renseignements | HEADLINE: Therapy for Minor Ailment
BODY:
Dymista is indicated for the symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older.
READ MORE
DYMISTA® is not recommended for use in children less than 6 years of age as safety and efficacy have not been established in this age group.
Consult the Product Monograph at https://health-products.canada.ca/dpd-bdpp/index-eng.jsp for more information about conditions of clinical use, contraindications, warnings, precautions, adverse reactions, interactions and dosing.
The Product Monograph is also available by calling 1-844-596-9526.
|  | 02432889 |
| Pharmascience | pms-BETAHISTINE | Product Availability | Disponibilité des produits | Please see attached. |  | 02330210, 02330237 |
| Pharmascience | pmsc-VENLAFAXINE XR | Product Availability | Disponibilité des produits | Pharmascience est heureux de vous annoncer le lancement de pmsc-VENLAFAXINE XR! |  | 02521466,02521482,02521474 |
| Pharmascience | pms-CINACALCET | New Product | Nouveau produit | Pharmascience is proud to announce the launch of pms-CINACALCET! |  | 02517604,02517612,02517620 |
| Sandoz | Sandoz Sitagliptin | New Product | Nouveau produit | Launch of Sandoz Sitagliptin |  | NA |
| Sandoz | Sandoz Sitagliptin-Metformin | New Product | Nouveau produit | Launch of Sandoz Sitagliptin-Metformin |  | NA |
| Teva | TEVA-CEFADROXIL, TEVA-TOPISONE (CREAM), TEVA-ALMOTRIPTAN | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products are now listed as benefits on the Saskatchewan Formulary effective December 1, 2022. |  | 02235134, 00804991, 02434849 |
| Teva | TEVA-TOPISONE (CREAM) | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product will be listed as a benefit on the Prince Edward Island Pharmacare Formulary effective December 28, 2022. |  | 00804991 |
| Teva | Teva-Diltiazem XC | New Product | Nouveau produit | Introducing generic alternative to TIAZAC® XC |  | 02429322, 02429330, 02429349, 02429357 |
| Apotex | pms-QUETIAPINE 200mg TABS 500 | Product Transition | Transition dans la production | Please see attached. |  | 00703486 |
| Apotex | pms-CLARITHROMYCIN 500mg TABS 250 | Product Transition | Transition dans la production | Please see attached. |  | 02278561 |
| Teva | Teva-Diltiazem XC | New Product | Nouveau produit | Introducing Teva-Diltiazem XC - generic alternative to Tiazac XC |  | 02429322, 02429330, 02429349, 02429357 |
| Teva | | Formulary Update | Mise à jour du formulaire | | | 345345 |
| Sandoz | Supeudol | Product Availability | Disponibilité des produits | Dear Customer,
Sandoz Canada Inc. wishes to inform you that the following products will be unavailable upon the depletion of inventory and for an indeterminate period. Please accept our apologies for any inconvenience this may cause.
For more information, please contact your local Sandoz Regional Manager or call our Customer Service at 1-800-361-3062.
Thank you. |  | 00392480,00392472 |
| Sandoz | Sandoz Prochlorperazine Suppository | Product Availability | Disponibilité des produits | Dear Customer,
Sandoz Canada Inc. wishes to inform you that the following product will be unavailable for an indeterminate period. Please accept our apologies for any inconvenience this may cause.
For more information, please contact your local Sandoz Regional Manager or call our Customer Service at 1-800-361-3062.
Thank you. |  | 00789720 |
| Pharmascience | pms-METHOTREXATE 2.5mg bottles of 100's | New Product | Nouveau produit | Line extension: pms-METHOTREXATE 2.5mg bottles of 100's |  | 02170698 |
| Apotex | KleanLyte | Product Availability | Disponibilité des produits | KleanLyte Celebrating 1 year on the market! |  | 80107241 |
| Sandoz | Sandoz Ambrisentan | New Product | Nouveau produit | New launch |  | 0000 |
| Sandoz | Sandoz Mycophenolate Mofetil | Product Appearance Up date | Nouvel aspect du produit | Dear Customer,
Sandoz Canada Inc. would like to announce a packaging improvement for PrSandoz® Mycophenolate Mofetil upon the depletion of current inventory. Please note that the UPC codes will also change.
For more information, please contact your local Sandoz Regional Manager.
Thank you. |  | 02320630,02313855 |
| Apotex | pms-IRBESARTAN 150mg 500 | Product Transition | Transition dans la production | Please see attached |  | 02317079 |
| Teva | Teva-Valsartan | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02356678 |
| Teva | Teva-Pregabalin | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce a product line extension for Teva-Pregabalin. |  | 02361159, 02361175, 02361183, 02361205, 02361221, 02361248 |
| Teva | TEVA-TERIFLUNOMIDE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available on the British Columbia Pharmacare Formulary as Special Authority effective July 7, 2022. |  | 02501090 |
| Teva | | Formulary Update | Mise à jour du formulaire | | | 02501090 |
| Teva | TEVA-NAPROXEN SODIUM, TEVA-NAPROXEN SODIUM DS | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products are listed on the Ontario Drug Benefit Formulary as Off-Formulary Interchangeable (OFI) effective August 31, 2022. |  | 00778389, 02026600 |
| Teva | Teva-Teriflunomide | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product will be listed on the Manitoba Drug Benefits and Interchangeability Formulary under Part 3 Exception Drug Status effective September 20, 2022. |  | 02501090 |
| Pharmascience | pharma-SIMVASTATIN 20mg TABS 500 | Product Transition | Transition dans la production | Please see attached. |  | 02469995 |
| Pharmascience | pms-ABACAVIR/LAMIVUDINE600/300mg T 3X10 | Product Availability | Disponibilité des produits | Please see attached. |  | 02458381 |
| Teva | TEVA-FLUTICASONE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following product is now available on the Nova Scotia Formulary as interchangeable (not insured) effective September 12, 2022. |  | 02453738 |
| Teva | TEVA-TERIFLUNOMIDE, TEVA-DESVENLAFAXINE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products will be listed on the Manitoba Drug Benefits and Interchangeability Formulary under Part 3 Exception Drug Status effective September 20, 2022. |  | 02501090, 02458217, 02458225 |
| Pharmascience | pms-DEFERASIROX FC (Type J) | New Product | Nouveau produit | Pharmascience is proud to announce the launch of pms-DEFERASIROX FC (Type J) |  | 02528290/02528312 |
| Teva | Teva-Pregabalin | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce a product line extension for Teva-Pregabalin. |  | 02361159, 02361175, 02361183, 02361205, 02361221, 02361248 |
| Pharmascience | pms-SILDENAFIL R 20mg TABS BLI 6X15 | Product Transition | Transition dans la production | Please see attached. |  | 02412179 |
| Mylan | FULPHILA ONE CERT | Important Announcement | Annonce importante | Immediate financial assistance for FULPHILA patients at pharmacy for up to a maximum of 25% of total cost of product to the patient. |  | 02484153 |
| Teva | Teva-Pregabalin | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce a product line extension for Teva-Pregabalin. |  | 02361159, 02361175, 02361183, 02361205, 02361221, 02361248 |
| Teva | Aermony RespiClick | Information Update | Mise à jour des renseignements | Aermony RespiClick |  | 02467895, 02467909, 02467917 |
| Pharmascience | pms-TERIFLUNOMIDE 14MG | Formulary Update | Mise à jour du formulaire | pms-TERIFLUNOMIDE 14MG will be registered on the RAMQ list on Aug 17, 2022 |  | 02500434 |
| Teva | TEVA-TERIFLUNOMIDE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available as a Special Authorization benefit on the New Brunswick Drug Plan Formulary effective June 30, 2022. |  | 02501090 |
| Teva | TEVA-TERIFLUNOMIDE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available as a Special Authorization benefit on the Newfoundland and Labrador Drug Formulary effective July 1, 2022. |  | 02501090 |
| Teva | Teva-Pregabalin | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce a product line extension for Teva-Pregabalin. |  | 02361159, 02361175, 02361175, 02361221, 02361248 |
| Teva | REVIA | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is listed on the Alberta Drug Benefit Formulary effective July 1, 2022. |  | 02213826 |
| Pharmascience | pms-ATORVASTATIN 10mg - 20mg - 40mg | Product Transition | Transition dans la production | Please see the attached the communication for pms-ATORVASTATIN |  | 02399377-02399385-02399393 |
| Pharmascience | pmsc-METFORMIN | New pack size | Nouveau format | NEW FORMAT BOTTLE OF 360'S NOW AVAILABLE! |  | 02520303 |
| Pharmascience | pms-CELECOXIB 200mg | Product Transition | Transition dans la production | Please see attached. |  | 02355450 |
| Sandoz | Sandoz Capsule June 2022 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Sandoz | Sandoz Capsule June 2022 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Sandoz | Sandoz Capsule June 2022 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Apotex | New Product Launch: Apo-Apixaban 2.5 mg & 5 mg Tabs | New Product | Nouveau produit | New Product Launch: Apo-Apixaban 2.5 mg & 5 mg Tabs |  | 02487381, 02487403 |
| Teva | Teva-Teriflunomide | New Product | Nouveau produit | Generic alternative to AUBAGIO® |  | 02501090 |
| Teva | TEVA-TERIFLUNOMIDE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products are listed on the Nova Scotia Formulary under Exception Status, effective June 6, 2022. |  | 02501090 |
| Sandoz | Milrinone Lactate Injection | Discontinuation | Abandon de produit | Notice of Discontinuation |  | 02244854 |
| Teva | Octreotide for Injectable Suspension | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products will be listed on the Manitoba Drug Benefits and Interchangeability Formulary effective June 1, 2022. |  | 02503751, 02503778, 02503786 |
| Sandoz | Sandoz Capsule May 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsule May 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsule May 2022 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Teva | Teva-Teriflunomide | New Product | Nouveau produit | Generic alternative to AUBAGIO® |  | 02501090 |
| Apotex | Ontario pan-Canadian Price Change: Effective May 31, 2022 | Price Update | Mise à jour des prix | Ontario pan-Canadian Price Change: Effective May 31, 2022 |  | 0 |
| Pharmascience | pms-ABACAVIR/LAMIVUDINE 600/300mg TAB 30 | Product Availability | Disponibilité des produits | Please see attached. |  | 02458381 |
| Sandoz | Acetylcysteine Solution | Product Availability | Disponibilité des produits | Now available |  | 02243098 |
| Teva | Teva-Teriflunomide | New Product | Nouveau produit | Generic alternative to AUBAGIO® |  | 02501090 |
| Apotex | New Product Launch: Apo-Teriflunomide 14 mg Tabs | New Product | Nouveau produit | New Product Launch: Apo-Teriflunomide 14 mg Tabs |  | 02500639 |
| Sandoz | Sandoz Teriflunomide | New Product | Nouveau produit | New launch |  | 0000 |
| Pharmascience | pms-Teriflunomide | New Product | Nouveau produit | Pharmascience is proud to launch pms-Teriflunomide |  | 02500434 |
| Sandoz | Methylphenidate SR | Discontinuation | Abandon de produit | Discontinuation |  | 02320312 |
| Sandoz | Topiramate Tab | Discontinuation | Abandon de produit | Discontinuation |  | 02431807, 02431815, 02431823 |
| Pharmascience | pmsc-METFORMIN | New pack size | Nouveau format | Pharmascience is now also offering pmsc-METFORMIN in a format of 360's! |  | 02520303 |
| Apotex | Manitoba pan-Canadian Price Change: Effective June 1, 2022 | Price Update | Mise à jour des prix | Manitoba pan-Canadian Price Change: Effective June 1, 2022 |  | 0 |
| Apotex | Nova Scotia Formulary Update: Effective May 9, 2022 | Formulary Update | Mise à jour du formulaire | Nova Scotia Formulary Update: Effective May 9, 2022 |  | 0 |
| Apotex | Saskatchewan Price Change: Effective Immediately | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective Immediately |  | 0 |
| Mylan | Introducing ABEVMY | New Product | Nouveau produit | Introducing ABEVMY (bevacizumab for injection) |  | 02522160, 02522179 |
| Pharmascience | pms-VALPROIC ACID E.C 500MG TABS | Important Announcement | Annonce importante | see attachment |  | 02229628 |
| Sandoz | Piperacillin and Tazobactam | New Product | Nouveau produit | Piperacillin and Tazobactam 40.5g |  | 02521539 |
| Teva | TEVA-DESVENLAFAXINE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following products are listed on the Ontario Drug Benefit Formulary as Off-Formulary Interchangeable (OFI) effective April 29, 2022. |  | 02458217, 02458225 |
| Sandoz | Sandoz Capsule April 2022 | Important Announcement | Annonce importante | New listings |  | 0000 |
| Sandoz | Sandoz Capsule April 2022 | Important Announcement | Annonce importante | xxx |  | 000 |
| Sandoz | Sandoz Capsule April 2022 | Important Announcement | Annonce importante | New listings |  | 0000 |
| Sandoz | Sandoz Capsule April 2022 | Important Announcement | Annonce importante | New listings |  | 0000 |
| Mylan | Introducing ABEVMY | New Product | Nouveau produit | Introducing ABEVMY (bevacizumab for injection), Viatris' third oncology biosimilar for Canadian patients. |  | 02522160,02522179 |
| Mylan | ACCESSA and Fulphila | Important Announcement | Annonce importante | Accessa vous présente son programme de soutien aux patients (PSP) Fulphila en collaboration avec Viatris : une gamme de services adaptés aux besoins des patients dans un contexte de traitements de chimiothérapie. |  | 02484153 |
| Mylan | ONE CERT for Fulphila | Important Announcement | Annonce importante | Introducing, a multi-use and multi-patient group and certificate number for patients dispensed Fulphila. |  | 02484153 |
| Teva | Teva-Desvenlafaxine | New Product | Nouveau produit | Generic alternative to PRISTIQ |  | 02458217, 02458225 |
| Teva | TEVA-VALGANCICLOVIR | Information Update | Mise à jour des renseignements | Please be informed that the following UPC is no longer available. The DIN remain the same for this product. New UPC and Item codes are listed below. |  | 02413825 |
| Teva | TEVA-DESVENLAFAXINE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following products are now available on the Nova Scotia Formulary as interchangeable (not insured) effective April 11, 2022. |  | 02458217, 02458225 |
| Teva | TEVA-DESVENLAFAXINE | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following products are listed on the Newfoundland and Labrador Interchangeable Drug Formulary effective April 1, 2022. |  | 02458217, 02458225 |
| Apotex | pms-ATOMOXETINE 18mg BLIS 2x15 | Product Transition | Transition dans la production | Change in packaging of pms-ATOMOXETINE 18mg BLIS 2x15 |  | 02381036 |
| Sandoz | Sandoz Lurasidone | New Product | Nouveau produit | New launch |  | 0000 |
| Apotex | pms-METFORMIN 850mg | Product Transition | Transition dans la production | Please see attached. |  | 02242589 |
| Apotex | pms-METFORMIN 500mg | Product Transition | Transition dans la production | Please see attached. |  | 02223562 |
| Apotex | METONIA 5MG TABS 100 & METONIA 1mg/mL SOL 500mL | Product Transition | Transition dans la production | Transition Notice from METONIA 5MG TABS 100 & METONIA 1mg/mL SOL 500mL to pms-METOCLOPRAMIDE 5MG TABS & pms-METOCLOPRAMIDE 1mg/mL SOL 500mL |  | 02230431 & 02230433 |
| Teva | TEVA-VALGANCICLOVIR | Information Update | Mise à jour des renseignements | Please be informed that the following UPC is no longer available. The DIN remain the same for this product. New UPC and Item codes are listed below. |  | 02413825 |
| Pharmascience | pharma-SIMVASTATIN 80MG BLIS | Product Substitution | Substitution de produit | Transition from pharma-SIMVASTATIN 80MG BLIS to pharma-SIMVASTATIN 80MG 100 |  | 02470012 |
| Pharmascience | PANTOPRAZOLE 40MG | Product Transition | Transition dans la production | REMINDER - TRANSITION NOTICE PANTOPRAZOLE 40MG |  | 02437945 |
| Sandoz | Sandoz Capsule March 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Capsule Sandoz March 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsule March 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Finasteride | Product Appearance Up date | Nouvel aspect du produit | Product appearance change for Sandoz Finasteride 5mg. |  | 02322579 |
| Mylan | FULPHILA ONE CERT Program | Important Announcement | Annonce importante | Effective immediately, the Fulphila copay program has moved to ONE CERT for all patients across the country adding additional efficiency to patient financial assistance. Click to learn more. |  | 02484153 |
| Sandoz | Isoproterenol Hydrochloride Injection USP | Product Availability | Disponibilité des produits | Now available |  | 00897639 |
| Teva | Teva OTC Allergy Products and First Aid Solutions | Information Update | Mise à jour des renseignements | With spring around the corner, help your patients find relief
with Teva’s assortment of over-the-counter allergy products,
as well as first aid solutions for itches and scratches.
Our products maintain the quality you know and trust from
Teva at competitive, low prices. |  | 00021288, 02097583, 02097583, 02097575 |
| Apotex | Manitoba Price Change: Effective April 1, 2022 | Price Update | Mise à jour des prix | Manitoba Price Change: Effective April 1, 2022 |  | 0 |
| Teva | TEVA-ROSUVASTATIN | Information Update | Mise à jour des renseignements | Please be informed that the following UPCs are no longer available. The DINs remain the same for this product. Replacement codes are listed below. |  | 02354608, 02354616, 02354624, 02354632 |
| Teva | Teva-Desvenlafaxine | New Product | Nouveau produit | Generic alternative to PRISTIQ® |  | 02458217, 02458225 |
| Sandoz | FLUOXETINE CAP | Discontinuation | Abandon de produit | Discontinuation |  | 02479486, 02479494 |
| Pharmascience | pms-LOSARTAN 25MG,50MG & 100MG | Product Availability | Disponibilité des produits | Available from Pharmascience pms-LOSARTAN 25MG,50MG & 100MG |  | 02309750, 02309769 & 02309777 |
| Apotex | Newfoundland Price Change: Effective March 8, 2022 | Price Update | Mise à jour des prix | Newfoundland Price Change: Effective March 8, 2022 |  | 0 |
| Sandoz | TRANSDERM-V (SCOPOLAMINE PATCH) | Discontinuation | Abandon de produit | Discontinuation |  | 80024336 |
| Pharmascience | pms-RISPERIDONE 3mg TABS BLI 6X10 | Product Transition | Transition dans la production | Please see attached. |  | 02252058 |
| Pharmascience | pms-RISPERIDONE 2mg TABS BLI 6X10 | Product Transition | Transition dans la production | Please see attached. |  | 02252031 |
| Pharmascience | pms-RISPERIDONE 3mg TABS 500 | Product Transition | Transition dans la production | Please see attached. |  | 02252058 |
| Pharmascience | pms-RISPERIDONE 2mg TABS 500 | Product Transition | Transition dans la production | Please see attached. |  | 02252031 |
| Pharmascience | pms-LOSARTAN 100mg | Product Availability | Disponibilité des produits | Back in Stock: pms-LOSARTAN 100mg |  | 02309777 |
| Apotex | Ontario Price Change: Effective February 28. 2022 | Price Update | Mise à jour des prix | Ontario Price Change: Effective February 28. 2022 |  | 0 |
| Apotex | Newfoundland and Labrador Formulary Update: Effective March 1, 2022 | Formulary Update | Mise à jour du formulaire | Newfoundland and Labrador Formulary Update: Effective March 1, 2022 |  | 0 |
| Sandoz | Bortezomib for Injection SDZ | New Product | Nouveau produit | New launch |  | 02503352 |
| Apotex | New Brunswick Price Change: Effective February 28, 2022 | Price Update | Mise à jour des prix | New Brunswick Price Change: Effective February 28. 2022 |  | 0 |
| Sandoz | Comtan Discontinuation | Discontinuation | Abandon de produit | Discontinuation |  | 0000 |
| Teva | ACT RIZATRIPTAN | Information Update | Mise à jour des renseignements | Please be informed that the following UPCs are no longer available. The DINs remain the same for this product. Replacement codes are listed below. |  | 02381702 |
| Teva | TEVA-TELMISARTAN HCTZ | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02330288, 02379252 |
| Sandoz | Sandoz Capsule February 2022 | Important Announcement | Annonce importante | new formulary listings |  | 0000 |
| Sandoz | Sandoz Capsule February 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsule February 2022 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsule February 2022 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Apotex | Alberta Price Change: Effective March 1, 2022 | Price Update | Mise à jour des prix | Alberta Price Change: Effective March 1, 2022 |  | 0 |
| Teva | Teva-Desvenlafaxine | New Product | Nouveau produit | Generic Alternative to PRISTIQ® |  | 02458217, 02458225 |
| Teva | TEVA-ROSUVASTATIN | Information Update | Mise à jour des renseignements | Please be informed that the following UPCs are no longer available. The DINs remain the same for this product. Replacement codes are listed below. |  | 02354608, 02354616, 02354624, 02354632 |
| Teva | Teva-Desvenlafaxine | New Product | Nouveau produit | Introducing Teva-Desvenlafaxine - Generic alternative to Pr PRISTIQ (R) |  | 02458217, 02458225 |
| Apotex | New Product Launch: Apo-Guanfacine XR 1 mg, 2 mg, 3 mg and 4 mg Tablets | New Product | Nouveau produit | New Product Launch: Apo-Guanfacine XR 1 mg, 2 mg, 3 mg and 4 mg Tablets |  | 02523728, 02523736, 02523744, 02523752 |
| Sandoz | Sandoz Clonidine | New Product | Nouveau produit | New launch |  | 0000 |
| Sandoz | Sandoz Tramadol | Product Transition | Transition dans la production | Product schedule change |  | 000 |
| Pharmascience | pms-LOSARTAN 25mg & 50mg | Product Availability | Disponibilité des produits | Back in Stock: pms-LOSARTAN 25mg & 50mg |  | 02309750 & 02309769 |
| Teva | Teva-Telmisartan HCTZ | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02330288, 02379252 |
| Teva | | Formulary Update | Mise à jour du formulaire | | | 02230584, 02230585, 02503751, 02503778, 02503786 |
| Apotex | NIHB Formulary Update: Effective Immediately | Formulary Update | Mise à jour du formulaire | NIHB Formulary Update: Effective Immediately |  | 0 |
| Apotex | Alberta Formulary Update: Effective February 1, 2022 | Formulary Update | Mise à jour du formulaire | Alberta Formulary Update: Effective February 1, 2022 |  | 02505762 |
| Teva | TEVA-TELMISARTAN HCTZ | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02330288 |
| Sandoz | Sandoz Capsule January 2022 | Information Update | Mise à jour des renseignements | new formulary listings |  | 0000 |
| Apotex | Manitoba Formulary Update: February 24, 2022 | Formulary Update | Mise à jour du formulaire | Manitoba Formulary Update: February 24, 2022 |  | 0 |
| Apotex | pms-AMLODIPINE 10mg | Product Transition | Transition dans la production | See attachment |  | 02469049 |
| Teva | TEVA-TELMISARTAN HCTZ | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02330288 |
| Teva | Octreotide for Injectable Suspension | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following products are listed on the Newfoundland and Labrador Drug Formulary effective January 1, 2022. |  | 02503751, 02503778, 02503786 |
| Sandoz | Fer Suspension | Discontinuation | Abandon de produit | Discontinuation | | 02246590 |
| Teva | OCTREOTIDE FOR INJECTABLE SUSPENSION | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available on the New Brunswick Drug Plan Formulary effective December 15, 2021. |  | 02503751, 02503778, 02503786 |
| Teva | Octreotide for Injectable Suspension | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following products have Exception Drug Status in Saskatchewan effective January 1, 2022. |  | 02503751, 02503778, 02503786 |
| Teva | Octreotide for Injectable Suspension | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce the following products are now available on the Nova Scotia Formulary effective January 10, 2022. |  | 02503751, 02503778, 02503786 |
| Apotex | Newfoundland Price Change Update: Effective Immediately | Price Update | Mise à jour des prix | Newfoundland Price Change Update: Effective Immediately |  | 0 |
| Sandoz | Sandoz Capsules December 2021 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Pharmascience | pms-PROGESTERONE 200mg GELCAPS BLI 2X15 | Product Availability | Disponibilité des produits | Please see attachment. |  | 02480247 |
| Pharmascience | pms-HYDROMORPHONE 1mg/mL SYRUP 500mL | Product Availability | Disponibilité des produits | Please see attached. |  | 01916386 |
| Pharmascience | pms-PROGESTERONE 100mg GELCAPS BLI 2X15 | Product Availability | Disponibilité des produits | Please see attached. |  | 02476576 |
| Apotex | Saskatchewan Formulary Update: Effective Immediately | Formulary Update | Mise à jour du formulaire | Saskatchewan Formulary Update: Effective Immediately |  | 0 |
| Teva | OCTREOTIDE FOR INJECTABLE SUSPENSION | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that that following products are listed on the Alberta Drug Benefit Formulary as Special Authorization effective December 1, 2021. |  | 02503751, 02503778, 02503786 |
| Teva | Loestrin | Information Update | Mise à jour des renseignements | Please be informed that the following pack size will be discontinued and no longer available. |  | 00353027 |
| Sandoz | Sandoz Capsule December 2021 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsules December 2021 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsules December 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Pharmascience | pms-ATORVASTATIN 80mg | Product Transition | Transition dans la production | see attached |  | 02477173 |
| Pharmascience | PHARMA-AMLODIPINE 2.5mg | Product Transition | Transition dans la production | see attached |  | 02469022 |
| Pharmascience | pms-ATORVASTATIN 80mg | Product Transition | Transition dans la production | see attached |  | 02477173 |
| Pharmascience | pms-AMOLDIPINE 5mg & 10mg | Product Transition | Transition dans la production | Please see attached |  | 02469030 & 02469049 |
| Teva | Octreotide for Injectable Suspension | New Product | Nouveau produit | Introducing Octreotide for Injectable Suspension - First generic alternative to Sandostatin LAR® |  | 02503751, 02503778, 02503786 |
| Teva | Octreotide for Injectable Suspension | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that that following products are listed on the Alberta Drug Benefit Formulary as Special Authorization effective December 1, 2021. |  | 02503751, 02503778, 02503786 |
| Teva | Octreotide for Injectable Suspension | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that that following products are listed on the Ontario Drug Benefit Drug Formulary effective November 30, 2021 |  | 02503751, 02503778, 02503786 |
| Pharmascience | pms-Metformin 850mg TABS 100 | Product Transition | Transition dans la production | Please see attached. |  | 02242589 |
| Apotex | Alberta Price Change: Effective December 1, 2021 | Price Update | Mise à jour des prix | Alberta Price Change: Effective December 1, 2021 |  | 0 |
| Apotex | Saskatchewan Price Change: Effective Immediately | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective Immediately |  | 0 |
| Apotex | British Columbia Price Change: Effective Immediately | Price Update | Mise à jour des prix | British Columbia Price Change: Effective Immediately |  | 0 |
| Teva | OCTREOTIDE FOR INJECTABLE SUSPENSION | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that that following products are listed on the Alberta Drug Benefit Formulary as Special Authorization effective December 1, 2021. |  | 02503751, 02503778, 02503786 |
| Teva | OCTREOTIDE FOR INJECTABLE SUSPENSION | None Selected | Teva Canada is pleased to announce that that following products are listed on the Ontario Drug Benefit Drug Formulary effective November 30, 2021. |  | 02503751, 02503778, 02503786 |
| Teva | Octreotide for Injectable Suspension | None Selected | Introducing first generic alternative to Sandostatin LAR® |  | 02503751, 02503778, 02503786 |
| Teva | Teva-Topilene | Information Update | Mise à jour des renseignements | Please be informed that the following pack size will be discontinued and no longer available. |  | 01927914 |
| Sandoz | Trandolapril | Product Appearance Up date | Nouvel aspect du produit | Appearance Change |  | NA |
| Pharmascience | pms-DESMOPRESSIN 0.2mg | Product Availability | Disponibilité des produits | Pharmascience is pleased to announce the re-launch of pms-DESMOPRESSIN 0.2mg |  | 02304376 |
| Apotex | Prince Edward Island Formulary Update: Effective November 22, 2021 | Formulary Update | Mise à jour du formulaire | Prince Edward Island Formulary Update: Effective November 22, 2021 |  | 0 |
| Apotex | Prince Edward Island Price Change: Effective November 22, 2021 | None Selected | Prince Edward Island Price Change: Effective November 22, 2021 |  | 0 |
| Pharma Science | pms-CELECOXIB 100mg CAPS 100 and 500 | Product Transition | Transition dans la production | Please see attached. |  | 02355442 |
| Teva | TEVA-BETAMETHASONE/CALCIPOTRIOL | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products will be listed on the Manitoba Drug Benefits and Interchangeability Formulary |  | 02427419, 02478307, 02478315, 02478323, 02478331, 02478358, 02466198 |
| Teva | Octreotide for Injectable Suspension | New Product | Nouveau produit | First generic alternative to PrSandostatin LAR® |  | 02503751, 02503778, 02503786 |
| Apotex | Nova Scotia Price Change: Effective November 8, 2021 | Price Update | Mise à jour des prix | Nova Scotia Price Change: Effective November 8, 2021 |  | 0 |
| Apotex | Saskatchewan Price Change: Effective November 1, 2021 | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective November 1, 2021 |  | 0 |
| Apotex | Newfoundland Price Change: Effective November 1, 2021 | Price Update | Mise à jour des prix | Newfoundland Price Change: Effective November 1, 2021 |  | 0 |
| Apotex | Manitoba Price Change: Effective November 25, 2021 | Price Update | Mise à jour des prix | Manitoba Price Change: Effective November 25, 2021 |  | 0 |
| Mylan | FULPHILA NOW LISTED | Formulary Update | Mise à jour du formulaire | Now listed on the PEI Pharmacare Formulary under the High Cost & Catastrophic Drug Programs |  | 02484153 |
| Pharmascience | Asaphen Chew 80mg | Product Transition | Transition dans la production | Please see attachment. |  | 02009013 |
| Pharmascience | pms-SILODOSIN | New Product | Nouveau produit | Pharmascience is proud to launch pms-SILODOSIN, a generic equivalent to Rapaflo |  | 02517779,02517787 |
| Pharmascience | pms-EVEROLIMUS | New Product | Nouveau produit | Pharmascience is proud to launch pms-EVEROLIMUS, a generic equivalent to Afinitor |  | 02504677,02504685,02504693 |
| Apotex | Alberta Price Change: Effective November 1, 2021 | Price Update | Mise à jour des prix | Alberta Price Change: Effective November 1, 2021 |  | 0 |
| Pharmascience | MYINFLA ER 0.5mg | New Product | Nouveau produit | Please see attachment. |  | 02519380 |
| Teva | TEVA-BETAMETHASONE/CALCIPOTRIOL | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products will be listed as Special Authorization on the Prince Edward Island Formulary effective October 25, 2021: |  | 02427419 |
| Teva | CEFAZOLIN SODIUM INJECTION | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available on the New Brunswick Drug Plan Formulary effective October 28, 2021. |  | 02108135 |
| Teva | Herzuma | New Product | Nouveau produit | A Herceptin® (trastuzumab) biosimilar available in Canada |  | 02480794, 02506211 |
| Teva | Teva-Teriparatide injectable | None Selected | Generic alternative to Forteo® |  | 02486423 |
| Teva | Octreotide for Injectable Suspension | New Product | Nouveau produit | First generic alternative to PrSandostatin LAR® |  | 02503751, 02503778, 02503786 |
| Sandoz | Sandoz Capsule October 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Sandoz | Sandoz Capsule October 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Pharmascience | pms-NIFEDIPINE ER 30mg | Product Appearance Up date | Nouvel aspect du produit | |  | 02418630 |
| Apotex | Apotex National Order Desk 2021 Holiday Hours | Information Update | Mise à jour des renseignements | Apotex National Order Desk 2021 Holiday Hours |  | 0 |
| Pharmascience | pms-LEVETIRACETAM | New Product | Nouveau produit | Pharmascience is proud to relaunch pms-LEVETIRACETAM |  | 02296101, 02296128,02296136 |
| Teva | Octreotide for Injectable Suspension | New Product | Nouveau produit | Introducing Octreotide for Injectable Suspension - First generic alternative to PrSandostatin LAR® |  | 02503751, 02503778, 02503786 |
| Teva | TEVA-IRBESARTAN HCTZ | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following products to the Canadian market. |  | 02330512, 02330520, 02330539 |
| Teva | TEVA-IRBESARTAN | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following products to the Canadian market. |  | 02316404, 02316412 |
| Teva | TEVA-BETAMETHASONE/CALCIPOTRIOL | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products will be listed as Special Authorization on the Prince Edward Island Formulary effective October 25, 2021 |  | 02427419 |
| Teva | Teva-Teriparatide Injection | Formulary Update | Mise à jour du formulaire | Approved by Health Canada as an interchangeable generic to Forteo®
Now listed and fully reimbursed on RAMQ! |  | 02486423 |
| Pharmascience | pms-ATOMOXETINE 10mg | Product Availability | Disponibilité des produits | Please see attachment |  | 02381028 |
| Teva | Teva-Metoprolol Uncoated | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02261898 |
| Apotex | British Columbia Price Change: Effective October 21, 2021 | Price Update | Mise à jour des prix | British Columbia Price Change: Effective October 21, 2021 |  | 0 |
| Apotex | Nova Scotia Price Change: Effective Immediately | Price Update | Mise à jour des prix | Nova Scotia Price Change: Effective Immediately |  | 0 |
| Pharmascience | MYINFLA | New Product | Nouveau produit | Please see attached. |  | 02519380 |
| Sandoz | TIMOLOL SDZ 0.5% 5ML EGEL CA | Product Availability | Disponibilité des produits | Product Availability |  | 02242276 |
| Sandoz | Dimethyl Fumarate Launch | New Product | Nouveau produit | New launch announcement |  | 0000 |
| Pharmascience | pms-DIMETHYL FUMARATE | New Product | Nouveau produit | Pharmascience is proud to launch pms-DIMETHYL FUMARATE, a generic equivalent to Tecfidera ®. Please see attached for more information including patient support program. |  | 02497026,02497034 |
| Apotex | National Price Change: Effective October 1, 2021 | Price Update | Mise à jour des prix | National Price Change: Effective October 1, 2021 |  | 0 |
| Apotex | Ontario Price Change: Effective September 30, 2021 | Price Update | Mise à jour des prix | Ontario Price Change: Effective September 30, 2021 |  | 0 |
| Apotex | Manitoba Price Change: Effective October 1, 2021 | Price Update | Mise à jour des prix | Manitoba Price Change: Effective October 1, 2021 |  | 0 |
| Apotex | Newfoundland Price Change: Effective October 1, 2021 | Price Update | Mise à jour des prix | Newfoundland Price Change: Effective October 1, 2021 |  | 0 |
| Apotex | Alberta Price Change: Effective October 1, 2021 | Price Update | Mise à jour des prix | Alberta Price Change: Effective October 1, 2021 |  | 0 |
| Apotex | Ontario Price Change: Effective October 1, 2021 | Price Update | Mise à jour des prix | Ontario Price Change: Effective October 1, 2021 |  | 0 |
| Apotex | New Brunswick Price Change: Effective September 30, 2021 | Price Update | Mise à jour des prix | New Brunswick Price Change: Effective September 30, 2021 |  | 0 |
| Teva | Teva-Teriparatide Injection | Formulary Update | Mise à jour du formulaire | Approved by Health Canada as an interchangeable generic to Forteo® |  | 02486423 |
| Teva | Irbesartan HCTZ | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02330512, 02330520, 02330539 |
| Teva | Irbesartan | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02316404, 02316412 |
| Teva | Metoprolol Uncoated | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02261898 |
| Pharmascience | pms-DESMOPRESSIN 0.1mg | Product Availability | Disponibilité des produits | Pharmascience is proud to relaunch pms-DESMOPRESSIN 0.1 mg |  | 02304368 |
| Sandoz | Imipenem/Cilastatin for Injection USP 250/250MG | Discontinuation | Abandon de produit | Discontinuation |  | 02358336 |
| Pharmascience | PMS-NITROFURANTOIN BID 100mg CAPS 100 | Product Appearance Up date | Nouvel aspect du produit | Please see attachment. |  | 02455676 |
| Pharmascience | pms-METHOTREXATE 2.5mg TABS BLI 3X10 | Price Update | Mise à jour des prix | Please see attachment. |  | 02170698 |
| Apotex | Nova Scotia Formulary Update: Effective September 6, 2021 | Formulary Update | Mise à jour du formulaire | Nova Scotia Formulary Update: Effective September 6, 2021 |  | 0 |
| Apotex | Saskatchewan Price Change: Effective Immediately | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective Immediately |  | 0 |
| Apotex | Saskatchewan Formulary Update: Effective September 1, 2021 | Formulary Update | Mise à jour du formulaire | Saskatchewan Formulary Update: Effective September 1, 2021 |  | 0 |
| Apotex | New Brunswick Formulary Update: Effective Immediately | Formulary Update | Mise à jour du formulaire | New Brunswick Formulary Update: Effective Immediately |  | 0 |
| Apotex | Saskatchewan Price Change: Effective September 1, 2021 | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective September 1, 2021 |  | 0 |
| Sandoz | FER CF | Discontinuation | Abandon de produit | Discontinuation |  | 02241802 |
| Sandoz | TIMOLOL SDZ 0.25% 5ML EGEL CA | Product Availability | Disponibilité des produits | PRODUCT AVAILABILITY |  | 02242275 |
| Sandoz | Sandoz Capsule September 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Sandoz | Sandoz Capsule September 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Teva | Teva-Dasatinib | Formulary Update | Mise à jour du formulaire | Teva Canada a le plaisir d’annoncer que le produit suivant figurera sur la Liste des médicaments du Québec à compter du 18 août, 2021 |  | 02478307, 02478315, 02478323, 02478358 |
| Teva | Teva-Rosuvastatin | Product Transition | Transition dans la production | Teva-Rosuvastatin will be transitioning to a new tablet appearance |  | 02354608, 02354616, 02354624, 02354632 |
| Teva | Teva-Simvastatin, Teva-Tolterodine | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following products to the Canadian market. |  | 02299593, 02299607, 02250152 |
| Sandoz | TOBRAMYCIN INH | Discontinuation | Abandon de produit | Discontinuation |  | 02443368 |
| Teva | Teva-Tolterodine; Teva-Simvastatin | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following products to the Canadian market. |  | 02299593, 02299607, 02250152 |
| Teva | Teva-Rosuvastatin | Product Transition | Transition dans la production | Teva-Rosuvastatin will be transitioning to a new tablet appearance |  | 02354608, 02354616, 02354624, 02354632 |
| Apotex | British Columbia Price Change: Effective Immediately | Price Update | Mise à jour des prix | British Columbia Price Change: Effective Immediately |  | 0 |
| Apotex | Ontario Formulary Update: Effective August 31, 2021 | Formulary Update | Mise à jour du formulaire | Ontario Formulary Update: Effective August 31, 2021 |  | 0 |
| Apotex | Ontario Price Change: Effective August 31, 2021 | Price Update | Mise à jour des prix | Ontario Price Change: Effective August 31, 2021 |  | 0 |
| Sandoz | Sandoz Capsule August 2021 | Important Announcement | Annonce importante | New formulary listing |  | 000 |
| Sandoz | Sandoz Capsule August 2021 | Important Announcement | Annonce importante | New formulary listing |  | 000 |
| Sandoz | Sandoz Capsule of August 2021 | Important Announcement | Annonce importante | new formulary listing |  | 000 |
| Teva | Teva-Dasatinib | Formulary Update | Mise à jour du formulaire | | | 02478307, 02478315, 02478323, 02478358 |
| Sandoz | Ci-Cal D | Discontinuation | Abandon de produit | Discontinuation |  | 80030816 |
| Apotex | Saskatchewan Price Change: Effective August 1, 2021 | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective August 1, 2021 |  | 0 |
| Apotex | New Brunswick Price Change: Effective Immediately | Price Update | Mise à jour des prix | New Brunswick Price Change: Effective Immediately |  | 0 |
| Apotex | New Brunswick Price Change: Effective July 29, 2021 | None Selected | New Brunswick Price Change: Effective July 29, 2021 |  | 0 |
| Apotex | pms-ESCITALOPRAM | New Product | Nouveau produit | Pharmascience launches pms-ESCITALOPRAM |  | 02469243,02469251 |
| Teva | Teva-Rosuvastatin | Product Transition | Transition dans la production | Teva-Rosuvastatin will be transitioning to a new tablet appearance:
-DIN’s will remain the same.
-Item and UPC numbers will change as the product transitions. |  | 02354608, 02354616, 02354624, 02354632 |
| Teva | Teva-Tolterodine | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following product to the Canadian market. |  | 02299593, 02299607 |
| Sandoz | DICLOFENAC SR 75MG | Discontinuation | Abandon de produit | Discontinuation |  | 2261901 |
| Sandoz | Cyproheptadine | Discontinuation | Abandon de produit | Discontinuation |  | 02245668 |
| Apotex | pms-METOCLOPRAMIDE HYDROCHLORIDE INJECTION | New Product | Nouveau produit | Pharmascience is pround to announce the launch of pms- METOCLOPRAMIDE HYDROCHLORIDE INJECTION. |  | 02510790 |
| Teva | TEVA-BETAMETHASONE/CALCIPOTRIOL | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available as a Special Authorization benefit on the New Brunswick Drug Plan Formulary effective July 15, 2021. |  | 02427419 |
| Mylan | FULPHILA CODIFICATION NOTICE | Information Update | Mise à jour des renseignements | Effective June 25, 2021, coding for the exception drug pegfilgrastim is possible if the clinical condition of the insured person corresponds to the recognized payment indications under code HE359. |  | 02484153 |
| Sandoz | Sandoz Capsule July 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Sandoz | Sandoz capsule July 2021 | Important Announcement | Annonce importante | xxx |  | 000 |
| Sandoz | Sandoz Capsule July 2021 | Important Announcement | Annonce importante | New formulary listings |  | 0000 |
| Sandoz | Orphenadrine | Product Availability | Disponibilité des produits | Product availability |  | 02243559 |
| Teva | Act Rizatriptan | Product Transition | Transition dans la production | Act Rizatriptan 10 mg tablets will be transitioning to new codes:
-Product Name, DIN and appearance will remain the same.
-Item, UPC, and wholesaler codes will change as the product transitions. |  | 02381702 |
| Teva | Teva- Cephalexin Susp, Teva-Anastrozole, Teva-Zopiclone, Teva-Bupropion XL, Teva-Buprenorphine/Naloxone, Teva-Cephalexin | Product Appearance Up date | Nouvel aspect du produit | Teva Canada is pleased to announce the following product transitions to the Teva label. The products are now available for sale. The description on your invoices and packing slips will now align to the description on the new label. Only the label look will change to “Teva”. UPC, DIN, item code, product appearance and markings will remain the same. |  | 00342092, 02394898, 02242481, 02439654, 02439662, 02453908, 00342084 |
| Teva | Teva-Buprenorphine/Naloxone, Teva-Cephalexin | Product Appearance Up date | Nouvel aspect du produit | Teva Canada is pleased to announce the following product transitions to the Teva label. The product is now available for sale. The description on your invoices and packing slips will now align to the description on the new label. Only the label look will change to “Teva”. UPC, DIN, item code, product appearance and markings will remain the same. |  | 02453908, 00342084 |
| Teva | Act Rizatriptan | Product Transition | Transition dans la production | Act Rizatriptan 10 mg tablets will be transitioning to a new formulation:
-Product Name, DIN and appearance will remain the same.
-Item, UPC, and wholesaler codes will change as the product transitions. |  | 02381702 |
| Pharmascience | pms-METHOTREXATE 2.5mg BLI 3X10 | New pack size | Nouveau format | Format change from blister 4X25 to 3X10 |  | 02170698 |
| Apotex | Apobiologix® Quebec Price Change: Lapelga® 6 mg/0.6 mL Sterile Solution for Injection | Price Update | Mise à jour des prix | Apobiologix® Quebec Price Change: Lapelga® 6 mg/0.6 mL Sterile Solution for Injection |  | 02474565 |
| Apotex | Newfoundland Price Change: Effective July 1, 2021 | Price Update | Mise à jour des prix | Newfoundland Price Change: Effective July 1, 2021 |  | 0 |
| Apotex | New Brunswick Price Change: Effective Immediately | Price Update | Mise à jour des prix | New Brunswick Price Change: Effective Immediately |  | 0 |
| Apotex | Saskatchewan Price Change: Effective July 1, 2021 | Price Update | Mise à jour des prix | Saskatchewan Price Change: Effective July 1, 2021 |  | 0 |
| Apotex | British Columbia Price Change: Effective July 15, 2021 | Price Update | Mise à jour des prix | British Columbia Price Change: Effective July 15, 2021 |  | 0 |
| Apotex | Nova Scotia Price Change: Effective July 12, 2021 | Price Update | Mise à jour des prix | Nova Scotia Price Change: Effective July 12, 2021 |  | 0 |
| Teva | Teva-Dasatinib | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products are now available as a Special Authorization benefit on the Newfoundland Drug Formulary effective July 1, 2021. |  | 02478307, 02478315, 02478323, 02478331, 02478358 |
| Teva | | None Selected | | | 02466198 |
| Pharmascience | pms-AMLODIPINE | Product Appearance Up date | Nouvel aspect du produit | pms-AMLODIPINE is now available - New format and product appearance.
See attached sell sheet for more information. |  | 02295148, 02284065,02284073 |
| Apotex | Prince Edward Island Price Change: Effective June 28, 2021 | Price Update | Mise à jour des prix | Prince Edward Island Price Change: Effective June 28, 2021 |  | 0 |
| Apotex | Newfoundland Price Change: Effective Immediately | Price Update | Mise à jour des prix | Newfoundland Price Change: Effective Immediately |  | 0 |
| Apotex | NIHB Formulary Update: Effective Immediately | Formulary Update | Mise à jour du formulaire | NIHB Formulary Update: Effective Immediately |  | 0 |
| Teva | Teva-Dasatinib, Teva-Febuxostat | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product will be listed as Special Authorization on the Prince Edward Island Formulary effective June 28, 2021: |  | 02478307, 02478315, 02478323, 02478358, 02466198 |
| Sandoz | Sandoz Capsule June 2021 | Important Announcement | Annonce importante | New formulary listing |  | 0000 |
| Sandoz | Sandoz Capsule June 2021 | None Selected | New formulary listing |  | 0000 |
| Sandoz | Sandoz Capsule June 2021 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Sandoz | Sandoz Capsule June 2021 | Important Announcement | Annonce importante | New formulary listings |  | 000 |
| Apotex | Ontario Price Change: Effective June 30, 2021 | Price Update | Mise à jour des prix | Ontario Price Change: Effective June 30, 2021 |  | 0 |
| Teva | Teva-Dasatinib, Teva-Febuxostat | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products are now available as a Special Authorization benefit on the New Brunswick Drug Plan Formulary effective June 30, 2021. |  | 02478307, 02478315, 02478323, 02478331, 02478358, 02466198 |
| Teva | Teva-Zopiclone, Teva Bupropion XL | Product Appearance Up date | Nouvel aspect du produit | Teva Canada is pleased to announce the following product transitions to the Teva label. The product is now available for sale. The description on your invoices and packing slips will now align to the description on the new label. Only the label look will change to “Teva”. UPC, DIN, item code, product appearance and markings will remain the same. |  | 02242481, 02439654, 02439662 |
| Teva | ACT Rizatriptan | Product Transition | Transition dans la production | Act Rizatriptan 10 mg tablets will be transitioning to a new formulation:
- Product Name, DIN and appearance will remain the same.
- Item, UPC, and wholesaler codes will change as the product transitions.
- The 6 UDs will be transitioning immediately, followed by the 12 UDs |  | 02381702 |
| Teva | Teva-Pindolol, Teva-Zopiclone | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following products to the Canadian market.
We are now ready to accept all orders. |  | 00869007, 00869015, 02246534, 02242481 |
| Mylan | FULPHILA PRICE CHANGE | Price Update | Mise à jour des prix | FULPHILA PRICE CHANGE |  | 02484153 |
| Apotex | British Columbia Price Changes | Price Update | Mise à jour des prix | British Columbia Price Changes |  | 0 |
| Apotex | New Brunswick Price Change: Effective Immediately | Price Update | Mise à jour des prix | New Brunswick Price Change: Effective Immediately |  | 0 |
| Teva | Teva-Pindolol, Teva-Zopiclone | Product Availability | Disponibilité des produits | Teva Canada is pleased to announce the availability of the following products to the Canadian market.
We are now ready to accept all orders.
|  | 00869007, 00869015, 02246534, 02242481 |
| Teva | Teva-Rosuvastatin | Product Transition | Transition dans la production | Teva-Rosuvastatin will be transitioning to a new tablet appearance:
DIN’s will remain the same.
Item and UPC numbers will change as the product transitions.
The 5 mg, 20mg, 40mg will begin transitioning immediately, followed by the 10 mg. |  | 02354608, 02354624, 02354632 |
| Teva | Teva-Febuxostat, Teva-Nabilone | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following products are now available on the British Columbia Pharmacare Formulary effective June 3, 2021. |  | 02466198, 02392925 |
| Teva | Teva-Dasatinib, Teva-Febuxostat | Formulary Update | Mise à jour du formulaire | Teva Canada is pleased to announce that the following product is now available under Special Authorization in the Nova Scotia Formulary effective June 7, 2021. |  | 02478307, 02478315, 02478323, 02478358, 02466198 |
| Teva | TEVA-TOPISONE | Product Appearance Update | ratio-TOPISONE has been transitioned to TEVA-TOPISONE. | Missing Attachment | 809187 |
| Apotex | Apo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg Tabs | Formulary Update | Apo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg Tabs |  | 2,470,780 |
| Apotex | Product Discontinuation: September 27, 2018 | Discontinuation | Product Discontinuation: September 27, 2018 |  | 0 |
| Apotex | Product Pack Discontinuation: September 20, 2018 | Discontinuation | Product Pack Discontinuation: September 20, 2018 |  | 0 |
| Teva | Methoxisal - Methoxacet | Discontinuation | The following back pain products are no longer available and are discontinued. | Missing Attachment | 2,236,872,019,663,750,000,000,000,000,000 |
| Teva | Allernix | Discontinuation | The following antihistamine products will be discontinued an no longer available. | Missing Attachment | 209,758,302,097,575 |
| Sandoz | Sandoz Lacosamide | New Product | New Product Sandoz Lacosamide |  | 2,474,670,024,746,890,000,000,000,000,000 |
| Teva | Teva-Lacosamide | New Product | A generic alternative to Vimpat®. | Missing Attachment | 2,472,902,024,729,100,000,000,000,000,000 |
| Apotex | Apo-Emtricitabine-Tenofovir 200/300 mg Tabs | Price Update | Apo-Emtricitabine-Tenofovir 200/300 mg Tabs |  | 2,452,006 |
| Teva | ACT QUETIAPINE | Product Transition | TEVA-QUETIAPINE has been transitioned to ACT QUETIAPINE. | Missing Attachment | 231,608,002,316,099,000,000,000,000,000,000,000,000 |
| Teva | ACT PIOGLITAZONE | Product Transition | ACT PIOGLITAZONE has been transitioned to ACT PIOGLITAZONE. | Missing Attachment | 230,286,102,302,888,000,000,000,000,000,000,000,000 |
| Teva | Teva-Trandolapril | New Product | A generic alternative to Mavik® | Missing Attachment | 2,415,429,024,154,370,000,000,000,000,000 |
| Teva | TEVA-TOLTERODINE LA | Formulary Update | TEVA-TOLTERODINE LA, previously covered as Special Access will now be covered as a Regular Benefit effective October 1, 2018. | Missing Attachment | 241,219,502,412,209 |
| Teva | TEVA-SOLIFENACIN | Formulary Update | TEVA-SOLIFENACIN, previously covered as Special Access will now be covered as a Regular Benefit effective October 1, 2018. | Missing Attachment | 239,790,002,397,919 |
| Teva | TEVA-ARIPIPRAZOLE | Formulary Update | TEVA-ARIPIPRAZOLE will be listed on the Ontario Drug Benefit Formulary effective September 27th. | Missing Attachment | 246,417,902,464,179 |
| Sandoz | Sandoz Esomeprazole | New Product | New Product Sandoz Esomeprazole |  | 246,092,002,460,939 |
| Mylan | Pyridoxine Hydrochloride Injection | Important Announcement | This is to confirm that the product below has not been discontinued and is currently available to order. | | 2,245,215 |
| Sandoz | Haloperidol LA | Product Availability | Anticipated backorder of Sandoz Haloperidol LA (decanoate) 100 mg/mL 5 mL vials |  | 9,999,999 |
| Sandoz | Haloperidol LA | Product Availability | Anticipated backorder of Sandoz Haloperidol LA (decanoate) 100 mg/mL 5 mL vials |  | 9,999,999 |
| Apotex | Apo-Pinaverium 50 mg & 100 mg tablets | New Product | Apo-Pinaverium 50 mg & 100 mg tablets |  | 246,967,702,469,685 |
| Sandoz | Sandoz Capsule at a Glance | Formulary Update | Formulary & Launch Update – Ontario |  | 24,687,000,246,871,900,000,000 |
| Apotex | Apo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg Tabs | Formulary Update | Apo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg Tabs |  | 2470780 |
| Apotex | British Columbia Price Change: Effective September 11, 2018 | Price Update | British Columbia Price Change: Effective September 11, 2018 |  | 0 |
| Teva | Teva-Aripiprazole | New Product | Generic alternative to Abilify®. | Missing Attachment | 246,414,402,464,152,000,000,000,000,000,000,000,000 |
| Apotex | British Columbia Formulary Update: September 7, 2018 | Formulary Update | British Columbia Formulary Update: September 7, 2018 |  | 0 |
| Apotex | Apo-Efavirenz-Emtricitabine-Tenofovir 600 mg / 200 mg / 300 mg Tabs | New Product | Apo-Efavirenz-Emtricitabine-Tenofovir 600 mg / 200 mg / 300 mg Tabs |  | 2,468,247 |
| Teva | TEVA-ARIPIPRAZOLE | Formulary Update | TEVA-ARIPIPRAZOLE has been listed on the British Columbia Pharmacare Formulary. | Missing Attachment | 246,417,902,464,187 |
| Apotex | Apo-Solifenacin 5 mg & 10 mg Tabs | New Product | Apo-Solifenacin 5 mg & 10 mg Tabs |  | 242,337,502,423,383 |
| Apotex | Apo-Metronidazole 500 mg Caps | Price Update | Apo-Metronidazole 500 mg Caps |  | 2,248,562 |
| Sandoz | Sandoz Ranitidine | Product Appearance Update | Appearance change |  | 224,322,902,243,230 |
